UBS maintains Cano Health at 'neutral' with a price target of $1.50

  • Investing.com
UBS maintains Cano Health at 'neutral' with a price target of $1.50

An analyst from UBS maintained Cano Health (NYSE: CANO ) at 'neutral' with a price target of $1.50 from a prior price target of $1.00.

Prior to this rating, Cano Health had 2 buy ratings, 6 hold ratings, and 2 sell ratings.

For consensus analyst estimates and price targets on Cano Health, click here. For more news on Cano Health, click here.

Cano Health's stock price closed at $1.42. They are up 0% in the last month and down -69.46% in the last 12 months.

According to Investing Pro, Cano Health's fair value is $1.38, a downside of 2.89%. Cano Health's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Cano Health's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100